Accelerating Biomarker-driven Patient Outcomes

Time: 9:25 am
day: Day Two AM


  • Rapid advances in early detection, monitoring, personalized medicine and RWE can transform medical innovation and patient outcomes
  • Arguably, however, CDx and Dx reimbursement models do little to reinforce translation into speed and outcomes, particularly in Europe
  • What alternative models are possible and emerging that could impact patients globally?